Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products, as well as medical supplies. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; offers pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression solution, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. Additionally, it manufactures, prepares, delivers, and distributes radiopharmaceuticals and related treatments; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Cardinal Health Inc.

UBS analyst Levi Spry maintained a Sell rating on Evolution Mining today and set a price target of A$12.20. According to TipRanks, Spry is a 5-star...

Evolution Mining  (CAHPF) Gets a Sell from UBS

Caro Holdings ( ($CAHO) ) has provided an announcement. On January 6, 2026, Caro Holdings, Inc. announced that Chief Executive Officer and Board me...

Caro Holdings CEO Resigns, COO Named Interim Successor

The latest update is out from Evolution Mining ( ($AU:EVN) ). Evolution Mining will release its financial report for the half year ended 31 Decembe...

Evolution Mining Sets Date for Half-Year Results and Investor Briefing

Analysts have been eager to weigh in on the Materials sector with new ratings on Evolution Mining (CAHPF – Research Report) and Lynas Rare Earths (...

Analysts Offer Insights on Materials Companies: Evolution Mining (OtherCAHPF) and Lynas Rare Earths (OtherLYSCF)

Companies in the Materials sector have received a lot of coverage today as analysts weigh in on Westgold Resources (WGXRF – Research Report) and Ev...

Analysts Have Conflicting Sentiments on These Materials Companies: Westgold Resources (OtherWGXRF) and Evolution Mining (OtherCAHPF)

Analysts have been eager to weigh in on the Materials sector with new ratings on Evolution Mining (CAHPF – Research Report), Aurelia Metals (AUMTF ...

Analysts Offer Insights on Materials Companies: Evolution Mining (OtherCAHPF), Aurelia Metals (OtherAUMTF) and Lynas Rare Earths (OtherLYSCF)

Analysts fell to the sidelines weighing in on AdvanSix (ASIX – Research Report), Rio Tinto Limited (RTNTF – Research Report) and Evolution Mining (...

Analysts Offer Insights on Materials Companies: AdvanSix (ASIX), Rio Tinto Limited (OtherRTNTF) and Evolution Mining (OtherCAHPF)

Companies in the Materials sector have received a lot of coverage today as analysts weigh in on Fletcher Building Limited (FRCEF – Research Report)...

Analysts Offer Insights on Materials Companies: Fletcher Building Limited (OtherFRCEF), Orica Limited (OtherOCLDF) and Evolution Mining (OtherCAHPF)

In a report released today, Paul Kaner from Ord Minnett maintained a Hold rating on Evolution Mining , with a price target of A$12.45. According to...

Ord Minnett Remains a Hold on Evolution Mining  (CAHPF)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cardinal Health (CAH – Research Report) and Option C...

Analysts Offer Insights on Healthcare Companies: Cardinal Health (CAH) and Option Care Health (OPCH)

In a report released on January 9, Mitch Ryan from Jefferies maintained a Sell rating on Evolution Mining , with a price target of A$9.90. The comp...

Jefferies Sticks to Its Sell Rating for Evolution Mining  (CAHPF)

In a report released today, Allen Lutz from Bank of America Securities reiterated a Buy rating on Cardinal Health, with a price target of $230.00. ...

Current Quarter	$2.37	Next Quarter	$2.78
Current Year	$10.06	Next Year	$11.14
QoQ Growth	+17.3%	YoY Growth	+10.7%
3Y EPS CAGR	+57.9%	Target Price	$234.00
Consensus	Buy	Upside	+6.9%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	CAH	$218.93	+1.88%	1.64M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	CAH	$218.93	+1.9%	1.64M
3
4
5
6

CAH

CAH

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Cardinal Health Inc. Data in Excel

Get Cardinal Health Inc. Data in Excel